Chemistry Reference
In-Depth Information
acetonide groups using I 2 in MeOH gave rise to the versatile triol 21 or 22,
which could readily be converted to the peracetyl Tn precursors. Alter-
natively the triols could be transformed, via resilylation with TBSCl, into
diol 3-acceptor 23 or 24, or by benzylidene formation to give specific
position 3 acceptor 25 or 26. This methodology was used to prepare
substantial quantities of the Tn antigen. In addition, we used these
intermediates for the ecient preparation of several O-linked tumor-
associated antigens such as TF, Sialyl-Tn and Sialyl-T antigens.
For the synthesis of the Tn cluster, we used the peracetyl Tn derivatives
23/24 and 25/26, and following standard, IIDQ-mediated, peptide coup-
ling procedures the trimeric clusters 31 and 32 were prepared (Scheme 7).
In these constructs, the amino terminus was acetylated and the
carboxy terminus liberated for further modification. Such derivatization
included coupling of 33/34 to a synthetic lipopeptide, tripalmitoyl-S-
glycerylcysteinylserine (Pam 3 CysSer, 35) as immunological activator to
afford fully synthetic derivatives 36 and 37. Alternatively, after global
deprotection of 38, conjugation of 39 to an immunogenic carrier protein
such as BSA or KLH produced the corresponding functional vaccines
(Scheme 8). 16
The initial experiments were to evaluate the antibody response to
vaccination of mice with either Tn(c)-pam lipopeptide 36 or more con-
ventional Tn(c)-KLH or Tn(c)-BSA conjugates. 16 In the bioconjugation
event, about 317 clusters per KLH were introduced, while BSA showed only
7 clusters per protein. These conjugates plus the adjuvant QS-21, as well as
36 in intralipid, or 36 in intralipid plus QS-21 were used to vaccinate
groups of five mice, and all of these constructs proved to be immunogenic.
Construct 39 conjugated with KLH plus QS-21 was the optimal vaccine,
inducing high IgM and IgG titers by ELISA, whereas sera of mice im-
munized with 36 [Tn(c)-Pam] in conjunction with QS-21 failed to show
strong reaction. The cell surface reactivities of anti-Tn(c) antibodies were
AcO
OAc
OH
OAc
HO
AcO
O
O
O
a
b
AcO
HO
AcO
N H 2
N HFmoc
N HFmoc
AcHN
N 3
AcHN
O
OBn
O
OBn
O
OH
23 R=H
24 R=Me
21 R=H
22 R=Me
25 R=H
26 R=Me
O
R
O
O
R
R
c
OAc
AcO
OAc
AcO
AcO
OAc
O
O
O
AcO
AcO
AcO
AcHN
AcHN
AcHN
O
R
O
R
R
O
O
d, c, d, e
O
N
N
OR 1
R 1 =Bn
R 1 =H
OBn
FmocHN
AcHN
H
f
O
O
O
R
O
R
O
NHAc
NHAc
OAc
OAc
27 R=H
28 R=Me
29 R=H, R 1 =Bn
30 R=Me, R 1 =Bn
31 R=H, R 1 =H
32 R=Me, R 1 =H
O
O
OAc
AcO
OAc
AcO
Scheme 7 Synthesis of the trimeric Tn cluster. (a) 1. Ac 2 O, DMAP, Et 3 N, CH 2 Cl 2 , 90%; 2.
AcSH; 3. 20% morpholine in DMF, 5 min; (b) Ac 2 O, DMAP, Et 3 N, CH 2 Cl 2 , 90%; 2. AcSH;
3. Pd/C, H 2 , MeOH, H 2 O, 75%. (c) 25/26 IIDQ, CH 2 Cl 2 , 85-97%; (d) 20% morpholine in
DMF, 90-100%, (e) Ac 2 O, CH 2 Cl 2 , 70-76%; (f) Pd/C, H 2 , MeOH, H 2 O, 85-95%.
 
Search WWH ::




Custom Search